INR 0.72
(-1.37%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 53 Million | -63.81 Million | 59.83 Million | 6.76 Million | -74.04 Million | -251.06 Million |
Net Income | -24.56 Million | 40 Thousand | 17.82 Million | 30.43 Million | 324.57 Million | -251.06 Million |
Depreciation & Amortization | 11.61 Million | 1.27 Million | - | 5724.00 | 4.07 Million | 16.3 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 66.65 Million | -65.13 Million | 43.88 Million | -23.76 Million | -71.17 Million | - |
Other non-cash items | 47 Thousand | 7000.00 | -1.88 Million | 84.78 Thousand | -331.51 Million | -16.3 Million |
Investing Cash Flow | -44.75 Million | -82.92 Million | 20.74 Million | 8.87 Million | 365.46 Million | - |
Investments in PPE | -48.4 Million | -81.96 Million | - | - | -198.59 Thousand | - |
Acquisitions | 4.57 Million | - | 20.5 Million | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -925 Thousand | -960 Thousand | 240 Thousand | 8.87 Million | 365.66 Million | - |
Financing Cash Flow | -1.23 Million | 149.99 Million | -83 Million | -14.15 Million | -290.41 Million | - |
Debt repayment | -1.19 Million | -150 Million | -83 Million | -14.14 Million | -290.39 Million | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -47 Thousand | 299.99 Million | -1000.00 | - | - | - |
Accounts receivables | 18.06 Million | -30.51 Million | 42.82 Million | - | - | - |
Accounts payables | 14.77 Million | 25.65 Million | -1.84 Million | - | - | - |
Inventory | 3.94 Million | -3.94 Million | 5.78 Million | 8.84 Million | -14.62 Million | - |
Other working capital | 44.64 Million | -56.33 Million | -2.86 Million | -32.6 Million | -56.54 Million | - |
Cash at beginning of period | 3.5 Million | 253 Thousand | 2.67 Million | 1.19 Million | 185.28 Thousand | 57.65 Thousand |
Cash at end of period | 10.52 Million | 3.5 Million | 253 Thousand | 2.67 Million | 1.19 Million | 185.28 Thousand |
Capital Expenditure | -48.4 Million | -81.96 Million | - | - | -198.59 Thousand | - |
Effect of forex changes on cash | - | - | 1000.00 | -1.00 | - | - |
Net cash flow / Change in cash | 7.01 Million | 3.25 Million | -2.42 Million | 1.48 Million | 1 Million | 127.63 Thousand |
Free Cash Flow | 4.6 Million | -145.77 Million | 59.83 Million | 6.76 Million | -74.24 Million | -251.06 Million |
Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -24.56 Million | -4.33 Million | -379 Thousand | -4.97 Million | 40 Thousand | 596 Thousand |
Depreciation & Amortization | 11.61 Million | 3.81 Million | 2.14 Million | 1.89 Million | 1.27 Million | 1 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 66.65 Million | - | - | - | -65.13 Million | -10.67 Million |
Other non-cash items | 47 Thousand | 8.14 Million | -2.14 Million | -1.89 Million | 7000.00 | 12.43 Million |
Investing Cash Flow | -44.75 Million | - | - | - | -82.92 Million | -36.91 Million |
Investments in PPE | -48.4 Million | - | - | - | -81.96 Million | -35.95 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -925 Thousand | - | - | - | -960 Thousand | -960 Thousand |
Financing Cash Flow | -1.23 Million | - | - | - | 149.99 Million | 37 Million |
Debt repayment | -1.19 Million | - | - | - | -150 Million | -37 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -47 Thousand | - | - | - | 299.99 Million | - |
Accounts receivables | - | - | - | - | -30.51 Million | -30.33 Million |
Accounts payables | - | - | - | - | 25.65 Million | 23.73 Million |
Inventory | 3.94 Million | - | - | - | -3.94 Million | -3.83 Million |
Other working capital | - | - | - | - | -56.33 Million | -243 Thousand |
Cash at beginning of period | 3.5 Million | 13.67 Million | 14.04 Million | 3.5 Million | 253 Thousand | 12.5 Million |
Cash at end of period | 10.52 Million | 21.29 Million | 13.67 Million | -4.97 Million | 3.5 Million | 3.5 Million |
Capital Expenditure | -48.4 Million | - | - | - | -81.96 Million | -35.95 Million |
Effect of forex changes on cash | - | - | - | - | - | 1000.00 |
Net cash flow / Change in cash | 7.01 Million | 7.62 Million | -379 Thousand | -8.47 Million | 3.25 Million | -8.99 Million |
Free Cash Flow | 4.6 Million | 7.62 Million | -379 Thousand | -4.97 Million | -145.77 Million | -45.03 Million |
MEDPLUS
WIB
WTII
ZAPP
HUI
DLMAF